Fig. 5From: Theranostic RGD@Fe3O4-Au/Gd NPs for the targeted radiotherapy and MR imaging of breast cancerMTT assay results of MCF-7. A SK-BR-3, B MCF-10a, C and MDA-MB-231. D Cell lines which were treated with Fe3O4Au/Gd@RGD and Fe3O4AuGd at a different concentration (0–2 Mm). (*significant difference with the control group, **significant difference of NPs with and without peptide at a specific concentration P-value < 0.05)Back to article page